Nantahala Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.07M | Buy |
|
|||||
|
2025
Q1 | $6.81M | Sell |
|
|||||
|
2024
Q4 | $7.41M | Buy |
|
|||||
|
2024
Q3 | $8.72M | Hold |
|
|||||
|
2024
Q2 | $9.3M | Sell |
|
|||||
|
2024
Q1 | $11.1M | Buy |
|
|||||
|
2023
Q4 | $7.89M | Buy |
|
|||||
|
2023
Q3 | $3.49M | Sell |
|
|||||
|
2023
Q2 | $6.76M | Sell |
|
|||||
|
2023
Q1 | $20.6M | Hold |
|
|||||
|
2022
Q4 | $24.8M | Sell |
|
|||||
|
2022
Q3 | $33.1M | Sell |
|
|||||
|
2022
Q2 | $51.2M | Sell |
|
|||||
|
2022
Q1 | $46.8M | Sell |
|
|||||
|
2021
Q4 | $62.4M | Buy |
|
|||||
|
2021
Q3 | $50.8M | Buy |
|
|||||
|
2021
Q2 | $44.5M | Buy |
|
|||||
|
2021
Q1 | $44.8M | Buy |
|
|||||
|
2020
Q4 | $40M | Buy |
|
|||||
|
2020
Q3 | $19.8M | Buy |
|